Additional treatment for pT3 prostate cancer: Now, later or never

BJU International

Volumn 100, Issue 5, 2007, Pages 977-979

  Dearnaley, David P ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER GRADING; CANCER RECURRENCE; DISEASE COURSE; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; METASTASIS; MORTALITY; MULTIVARIATE ANALYSIS; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RISK REDUCTION; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE;

AGED; COMBINED MODALITY THERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 35148890392     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07177.x     Document Type: Note

References (17)

1. Bolla M, van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005 366 : 572 8
2. Thompson IM Jr., Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006 296 : 2329 35
3. de Reijke TM. Adjuvant radiotherapy results following radical prostatectomy - a critical review. Eur Urol Suppl 2007 6 : 512 5
4. Krupski TL, Saigal CS, Hanley J, Schonlau M, Litwin MS. Patterns of care for men with prostate cancer after failure of primary treatment. Cancer 2006 107 : 258 65
5. Lee LW, Clarke NW, Ramani VA, Cowan RA, Wylie JP, Logue JP. Adjuvant and salvage treatment after radical prostatectomy: current practice in the UK. Prostate Cancer Prostatic Dis 2005 8 : 229 34
6. Swanson GP, Hussey MA, Tangen CM et al. Predominant treatment failure in postprostatectomy patients is local. analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol 2007 25 : 2225 9
7. Collette L, van Poppel H, Bolla M et al. Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC Trial 22911) Eur J Cancer 2005 41 : 2662 72
8. van der Kwast TH, Collette L, Van Poppel H et al. Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911). Virchows Arch 2006 449 : 428 34
9. Wiegel T, Bottke D, Willich N et al. Phase III results of adjuvant radiotherapy (RT) versus wait and see (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP) (ARO 96-02/AUO AP 09/95). ASCO Prostate Cancer Symposium; 2007; Orlando, Florida, USA : J Clin Oncol 2007 18S : Abstract 5060
10. Denham JW, Steigler A, Lamb DS et al. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol 2005 6 : 841 50
11. D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A, Kantoff PW. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA 2004 292 : 821 7
12. Pilepich MV, Winter K, John MJ et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001 50 : 1243 52
13. Messing EM, Manola J, Yao J et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 2006 7 : 472 9
14. Bolla M, Collette L, Blank L et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002 360 : 103 6
15. Pilepich MV, Winter K, Lawton CA et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - long-term results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 2005 61 : 1285 90
16. Roach M, DeSilvio M, Lawton C et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 2003 21 : 1904 11
17. Stephenson AJ, Scardino PT, Kattan MW et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007 25 : 2035 41